FIXX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 16.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $13,375.58

Homology Medicines Insider Trading History Chart

Homology Medicines Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 03/25/2024 05:00 PM ET

Days: 30 | 90 | 365

Strange new buyer driving up gold

From Stansberry Research | Ad

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

Homology Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/9/2024	Arthur Tzianabos	Director	Sell	26,074	$0.29	$7,431.09	257,556
1/3/2024	Paul Alloway	Insider	Sell	14,560	$0.29	$4,149.60	56,072
9/6/2023	Albert Seymour	Insider	Sell	2,896	$0.58	$1,665.20	301,748
8/2/2023	Julie Jordan	Insider	Sell	198	$0.66	$129.69	5,540
3/2/2023	Paul Alloway	Insider	Sell	21,930	$0.73	$15,899.25	33,412
1/9/2023	Arthur Tzianabos	Director	Sell	21,232	$0.70	$14,756.24	216,790
1/9/2023	Michael Lee Blum	Insider	Sell	4,908	$0.70	$3,411.06	27,076
1/5/2022	Albert Seymour	Insider	Sell	3,322	$1.89	$6,278.58
1/5/2022	Arthur Tzianabos	CEO	Sell	10,708	$1.89	$20,238.12
1/5/2022	Timothy P. Kelly	COO	Sell	2,812	$1.89	$5,314.68
1/5/2022	W. Bradford Smith	CFO	Sell	4,364	$1.89	$8,247.96
9/3/2021	Timothy P. Kelly	Insider	Sell	108	$3.85	$415.80

Strange new buyer driving up gold

From Stansberry Research | Ad

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

SEC Filings (Institutional Ownership Changes) for Homology Medicines (NASDAQ:FIXX)

31.32% of Homology Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Homology Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/11/2024	Vanguard Group Inc.	1,939,590	$1.18M	0.0%	-5.2%	3.355%
2/15/2024	Vanguard Group Inc.	1,939,590	$1.18M	0.0%	-5.2%	3.355%
2/15/2024	Newtyn Management LLC	1,399,260	$0.85M	0.2%	N/A	2.420%
2/14/2024	ADAR1 Capital Management LLC	293,676	$0.18M	0.1%	N/A	0.508%
2/12/2024	George Kaiser Family Foundation	306,514	$0.19M	0.0%	+679.5%	0.530%
1/30/2024	BML Capital Management LLC	748,108	$0.46M	0.3%	N/A	1.294%
11/13/2023	Acadian Asset Management LLC	130,047	$0.15M	0.0%	-44.2%	0.225%
11/13/2023	George Kaiser Family Foundation	39,320	$46K	0.0%	N/A	0.068%
11/6/2023	Assenagon Asset Management S.A.	24,392	$29K	0.0%	-50.7%	0.042%
8/11/2023	Renaissance Technologies LLC	299,100	$0.27M	0.0%	-3.3%	0.518%
8/11/2023	BlackRock Inc.	1,107,077	$0.98M	0.0%	-8.0%	1.916%
8/11/2023	Geode Capital Management LLC	365,199	$0.32M	0.0%	-5.4%	0.632%
8/11/2023	Northern Trust Corp	66,348	$59K	0.0%	-30.0%	0.115%
7/25/2023	Assenagon Asset Management S.A.	49,516	$44K	0.0%	+179.4%	0.086%
5/16/2023	RBF Capital LLC	58,700	$60K	0.0%	-21.6%	0.102%
5/12/2023	Renaissance Technologies LLC	309,217	$0.32M	0.0%	-7.2%	0.535%
5/12/2023	BlackRock Inc.	1,203,542	$1.24M	0.0%	-8.0%	2.082%
5/12/2023	Bank of America Corp DE	423,589	$0.44M	0.0%	+17.1%	0.733%
5/12/2023	Dimensional Fund Advisors LP	135,740	$0.14M	0.0%	-13.9%	0.235%
5/11/2023	FMR LLC	74,429	$77K	0.0%	+17.1%	0.129%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	172,175	$0.18M	0.0%	-12.6%	0.298%
2/15/2023	Millennium Management LLC	241,004	$0.30M	0.0%	-47.5%	0.419%
2/14/2023	Marshall Wace LLP	20,775	$26K	0.0%	-31.2%	0.036%
2/13/2023	Renaissance Technologies LLC	333,153	$0.42M	0.0%	-12.1%	0.580%
2/13/2023	GSA Capital Partners LLP	64,818	$82K	0.0%	-39.4%	0.113%
2/10/2023	Bank of America Corp DE	361,621	$0.46M	0.0%	+4.5%	0.629%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	196,976	$0.25M	0.0%	-15.4%	0.343%
2/9/2023	Dimensional Fund Advisors LP	157,612	$0.20M	0.0%	-20.6%	0.274%
2/9/2023	Citigroup Inc.	62,015	$78K	0.0%	-30.0%	0.108%
11/15/2022	Algert Global LLC	34,976	$56K	0.0%	-15.8%	0.061%
11/15/2022	Vanguard Group Inc.	2,045,596	$3.29M	0.0%	+6.1%	3.559%
11/15/2022	Marshall Wace LLP	30,175	$48K	0.0%	+40.4%	0.052%
11/15/2022	BlackRock Inc.	1,635,331	$2.63M	0.0%	-1.3%	2.845%
11/14/2022	Renaissance Technologies LLC	379,100	$0.61M	0.0%	+52.4%	0.660%
11/14/2022	Ergoteles LLC	108,883	$0.18M	0.0%	-43.7%	0.190%
11/10/2022	Dimensional Fund Advisors LP	198,514	$0.32M	0.0%	-4.2%	0.346%
11/10/2022	UBS Group AG	33,254	$54K	0.0%	-82.5%	0.058%
10/5/2022	Vida Ventures Advisors LLC	696,289	$1.12M	1.0%	-9.7%	1.213%
8/18/2022	Goldman Sachs Group Inc.	147,296	$0.29M	0.0%	-60.4%	0.257%
8/16/2022	Price T Rowe Associates Inc. MD	66,000	$0.13M	0.0%	-5.2%	0.115%
8/15/2022	State Street Corp	135,134	$0.27M	0.0%	-86.4%	0.235%
8/15/2022	Cubist Systematic Strategies LLC	28,140	$55K	0.0%	N/A	0.049%
8/15/2022	Millennium Management LLC	721,964	$1.42M	0.0%	N/A	1.258%
8/15/2022	Vivo Capital LLC	370,068	$0.73M	0.1%	-56.6%	0.645%
8/13/2022	Virtu Financial LLC	17,377	$34K	0.0%	N/A	0.030%
8/13/2022	Renaissance Technologies LLC	248,800	$0.49M	0.0%	+6.3%	0.434%
8/12/2022	Northern Trust Corp	93,500	$0.18M	0.0%	-77.1%	0.163%
8/12/2022	FMR LLC	715,999	$1.41M	0.0%	-16.4%	1.248%
8/12/2022	Franklin Resources Inc.	34,685	$68K	0.0%	-32.8%	0.060%
8/11/2022	UBS Group AG	190,122	$0.38M	0.0%	+677.7%	0.331%
8/11/2022	JPMorgan Chase & Co.	709,956	$1.40M	0.0%	-3.1%	1.237%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	227,197	$0.45M	0.0%	+16.0%	0.396%
7/29/2022	Russell Investments Group Ltd.	42,814	$83K	0.0%	-11.4%	0.075%
7/27/2022	Bailard Inc.	23,750	$47K	0.0%	N/A	0.041%
7/27/2022	Assenagon Asset Management S.A.	20,145	$40K	0.0%	N/A	0.035%
6/7/2022	Bank of America Corp DE	85,682	$0.26M	0.0%	-40.4%	0.149%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	134,401	$0.41M	0.0%	-8.6%	0.234%
5/18/2022	BNP Paribas Arbitrage SA	100,647	$0.31M	0.0%	-14.6%	0.175%
5/17/2022	Mirabella Financial Services LLP	17,300	$53K	0.0%	N/A	0.030%
5/16/2022	Goldman Sachs Group Inc.	371,842	$1.13M	0.0%	-43.6%	0.648%
5/16/2022	State Street Corp	990,911	$3.01M	0.0%	+17.1%	1.727%
5/16/2022	Invesco Ltd.	15,773	$48K	0.0%	-50.8%	0.027%
5/16/2022	UBS Group AG	24,448	$74K	0.0%	-30.9%	0.043%
5/13/2022	Renaissance Technologies LLC	234,000	$0.71M	0.0%	+60.3%	0.408%
5/13/2022	Bellevue Group AG	1,647,122	$5.01M	0.1%	-5.2%	2.870%
5/13/2022	Northern Trust Corp	408,994	$1.24M	0.0%	-4.1%	0.713%
5/13/2022	Vanguard Group Inc.	1,784,386	$5.42M	0.0%	-8.7%	3.109%
5/13/2022	Dimensional Fund Advisors LP	328,446	$1M	0.0%	+19.1%	0.572%
5/12/2022	BlackRock Inc.	3,869,946	$11.77M	0.0%	+7.9%	6.744%
5/12/2022	Acadian Asset Management LLC	56,307	$0.17M	0.0%	-36.0%	0.098%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	195,914	$0.60M	0.0%	-3.8%	0.341%
5/11/2022	Raymond James & Associates	16,869	$51K	0.0%	N/A	0.029%
5/11/2022	JPMorgan Chase & Co.	732,829	$2.23M	0.0%	-6.9%	1.277%
5/11/2022	GSA Capital Partners LLP	228,365	$0.69M	0.1%	+16.8%	0.398%
5/10/2022	Mirae Asset Global Investments Co. Ltd.	134,401	$0.41M	0.0%	-8.6%	0.234%
5/5/2022	Russell Investments Group Ltd.	48,301	$0.15M	0.0%	-46.3%	0.084%
5/4/2022	Arizona State Retirement System	10,042	$31K	0.0%	N/A	0.018%
4/29/2022	Nisa Investment Advisors LLC	55,000	$0.17M	0.0%	N/A	0.096%
4/21/2022	Virginia Retirement Systems ET AL	19,800	$60K	0.0%	-22.7%	0.035%
2/19/2022	Woodline Partners LP	967,071	$3.52M	0.1%	N/A	1.692%
2/15/2022	Dimension Capital Management LLC	11,001	$40K	0.0%	N/A	0.019%
2/14/2022	PDT Partners LLC	15,907	$58K	0.0%	N/A	0.028%
2/14/2022	Virtus ETF Advisers LLC	37,588	$0.14M	0.1%	+30.6%	0.066%
2/14/2022	GSA Capital Partners LLP	195,596	$0.71M	0.1%	+45.4%	0.342%
2/10/2022	Acadian Asset Management LLC	88,000	$0.32M	0.0%	-62.1%	0.154%
2/10/2022	TD Asset Management Inc.	33,898	$0.12M	0.0%	+100.0%	0.059%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	203,564	$0.74M	0.0%	+82.0%	0.356%
2/9/2022	BNP Paribas Arbitrage SA	117,858	$0.43M	0.0%	+1,076.9%	0.206%
2/8/2022	Mirae Asset Global Investments Co. Ltd.	147,079	$0.54M	0.0%	+18.7%	0.257%
2/8/2022	Northern Trust Corp	426,397	$1.55M	0.0%	+0.7%	0.746%
2/7/2022	SG Americas Securities LLC	17,751	$65K	0.0%	-41.3%	0.031%
2/3/2022	OUP Management Co. LLC	64,000	$0.23M	0.1%	N/A	0.112%
2/3/2022	Virginia Retirement Systems ET AL	25,600	$93K	0.0%	+55.2%	0.045%
1/28/2022	Allspring Global Investments Holdings LLC	70,849	$0.26M	0.0%	N/A	0.124%
1/21/2022	Russell Investments Group Ltd.	89,992	$0.33M	0.0%	-25.5%	0.157%
12/14/2021	UBS Asset Management Americas Inc.	71,477	$0.56M	0.0%	-11.7%	0.125%
11/16/2021	Two Sigma Investments LP	161,129	$1.27M	0.0%	N/A	0.282%
11/16/2021	Wellington Management Group LLP	782,200	$6.16M	0.0%	-67.3%	1.370%
11/16/2021	Metropolitan Life Insurance Co NY	11,907	$94K	0.0%	N/A	0.021%
11/15/2021	Cubist Systematic Strategies LLC	62,133	$0.49M	0.0%	+20.5%	0.109%

Data available starting January 2016

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.

Today's Range

Now: N/A

50 Day Range

MA: $0.49

$0.30

$0.93

52 Week Range

Now: N/A

Volume

401,400 shs

Average Volume

390,307 shs

Market Capitalization

$54.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Homology Medicines?: Homology Medicines' top insider investors include:
Albert Seymour (Insider)
Arthur Tzianabos (Director)
Paul Alloway (Insider)
Michael Lee Blum (Insider)
Julie Jordan (Insider)
Learn More about top insider investors at Homology Medicines.